Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...

BostonGene RNA Transcriptome Profiling Reveals New ADC Targets in Advanced Solid Tumors

BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...
Phys.org

Computational tool incorporates transcriptome size to improve RNA-seq analysis

To get more out of RNA-seq analysis, scientists at St. Jude Children's Research Hospital created ReDeconv, an algorithmic tool that accounts for transcriptome size differences to unmask those ...
ascopubs.org

Comprehensive whole genome and transcriptome analysis of patients with advanced solid tumor treated with immune checkpoint inhibitor therapy in the pan-cancer cohorts from the ...

Single cell sequencing reveals T follicular helper cells as the link between combination ICI therapy and the development of increased IRAEs. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...